Literature DB >> 19471615

Adopting an orphan drug: rufinamide for Lennox-Gastaut syndrome.

Susan T Herman.   

Abstract

Entities:  

Year:  2009        PMID： 19471615      PMCID： PMC2685884          DOI： 10.1111/j.1535-7511.2009.01298.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  7 in total

Review 1.  Rufinamide.

Authors:  Santiago Arroyo
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

2.  Treatment of pediatric epilepsy: expert opinion, 2005.

Authors:  James W Wheless; Dave F Clarke; Daniel Carpenter
Journal:  J Child Neurol       Date:  2005-12       Impact factor: 1.987

Review 3.  Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  J A French; A M Kanner; J Bautista; B Abou-Khalil; T Browne; C L Harden; W H Theodore; C Bazil; J Stern; S C Schachter; D Bergen; D Hirtz; G D Montouris; M Nespeca; B Gidal; W J Marks; W R Turk; J H Fischer; B Bourgeois; A Wilner; R E Faught; R C Sachdeo; A Beydoun; T A Glauser
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

Review 4.  Treatment of Lennox-Gastaut syndrome.

Authors:  E Hancock; H Cross
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 5.  Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology.

Authors:  Alexis Arzimanoglou; Jacqueline French; Warren T Blume; J Helen Cross; Jan-Peter Ernst; Martha Feucht; Pierre Genton; Renzo Guerrini; Gerhard Kluger; John M Pellock; Emilio Perucca; James W Wheless
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

Review 6.  Treatment of pediatric epilepsy: European expert opinion, 2007.

Authors:  James W Wheless; Dave F Clarke; Alexis Arzimanoglou; Daniel Carpenter
Journal:  Epileptic Disord       Date:  2007-12       Impact factor: 1.819

7.  Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome.

Authors:  T Glauser; G Kluger; R Sachdeo; G Krauss; C Perdomo; S Arroyo
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910
  7 in total
  1 in total

Review 1.  Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.

Authors:  Heather Ann Wier; Ana Cerna; Tsz-Yin So
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.